Literature DB >> 21912369

Use of the EpiAirway model for characterizing long-term host-pathogen interactions.

Dabin Ren1, Dayle A Daines.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) are human-adapted Gram-negative bacteria that can cause recurrent and chronic infections of the respiratory mucosa (1; 2). To study the mechanisms by which these organisms survive on and inside respiratory tissues, a model in which successful long-term co-culture of bacteria and human cells can be performed is required. We use primary human respiratory epithelial tissues raised to the air-liquid interface, the EpiAirway model (MatTek, Ashland, MA). These are non-immortalized, well-differentiated, 3-dimensional tissues that contain tight junctions, ciliated and nonciliated cells, goblet cells that produce mucin, and retain the ability to produce cytokines in response to infection. This biologically relevant in vitro model of the human upper airway can be used in a number of ways; the overall goal of this method is to perform long-term co-culture of EpiAirway tissues with NTHi and quantitate cell-associated and internalized bacteria over time. As well, mucin production and the cytokine profile of the infected co-cultures can be determined. This approach improves upon existing methods in that many current protocols use submerged monolayer or Transwell cultures of human cells, which are not capable of supporting bacterial infections over extended periods(3). For example, if an organism can replicate in the overlying media, this can result in unacceptable levels of cytotoxicity and loss of host cells, arresting the experiment. The EpiAirway model allows characterization of long-term host-pathogen interactions. Further, since the source for the EpiAirway is normal human tracheo-bronchial cells rather than an immortalized line, each is an excellent representation of actual human upper respiratory tract tissue, both in structure and in function(4). For this method, the EpiAirway tissues are weaned off of anti-microbial and anti-fungal compounds for 2 days prior to delivery, and all procedures are performed under antibiotic-free conditions. This necessitates special considerations, since both bacteria and primary human tissues are used in the same biosafety cabinet, and are co-cultured for extended periods.

Entities:  

Mesh:

Year:  2011        PMID: 21912369      PMCID: PMC3216630          DOI: 10.3791/3261

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  Comparison of human tracheal/bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies.

Authors:  Nagendra V Chemuturi; Patrick Hayden; Mitch Klausner; Maureen D Donovan
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

2.  An in vitro approach to assess the toxicity of inhaled tobacco smoke components: nicotine, cadmium, formaldehyde and urethane.

Authors:  Dominique Balharry; Keith Sexton; Kelly A BéruBé
Journal:  Toxicology       Date:  2007-11-09       Impact factor: 4.221

Review 3.  Airway mucus function and dysfunction.

Authors:  John V Fahy; Burton F Dickey
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

4.  The efficacy of Echinacea in a 3-D tissue model of human airway epithelium.

Authors:  M Sharma; R Schoop; J B Hudson
Journal:  Phytother Res       Date:  2010-06       Impact factor: 5.878

Review 5.  Nontypeable Haemophilus influenzae as a pathogen in children.

Authors:  Timothy F Murphy; Howard Faden; Lauren O Bakaletz; Jennelle M Kyd; Arne Forsgren; Jose Campos; Mumtaz Virji; Stephen I Pelton
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

Review 6.  Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.

Authors:  T F Murphy; M A Apicella
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  Effect of cyclodextrins on the complexation and nasal permeation of melatonin.

Authors:  R Jayachandra Babu; Pankaj Dayal; Mandip Singh
Journal:  Drug Deliv       Date:  2008-08       Impact factor: 6.419

8.  Genomic biomarkers of pulmonary exposure to tobacco smoke components.

Authors:  Keith Sexton; Dominique Balharry; Kelly A BéruBé
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

9.  Opposing roles of PAK2 and PAK4 in synergistic induction of MUC5AC mucin by bacterium NTHi and EGF.

Authors:  Yuxian Huang; Fumi Mikami; Hirofumi Jono; Wenhong Zhang; Xinhua Weng; Tomoaki Koga; Haidong Xu; Chen Yan; Hirofumi Kai; Jian-Dong Li
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

10.  Nontypeable Haemophilus influenzae isolated from intractable acute otitis media internalized into cultured human epithelial cells.

Authors:  Muneki Hotomi; Jun Arai; Dewan S Billal; Shin Takei; Yorihiko Ikeda; Masashi Ogami; Masamitsu Kono; Levent B Beder; Kazuo Toya; Michio Kimura; Noboru Yamanaka
Journal:  Auris Nasus Larynx       Date:  2009-06-07       Impact factor: 1.863

  10 in total
  9 in total

1.  Crystal Structure of VapBC-1 from Nontypeable Haemophilus influenzae and the Effect of PIN Domain Mutations on Survival during Infection.

Authors:  Ashley L Molinaro; Maithri M Kashipathy; Scott Lovell; Kevin P Battaile; Nathan P Coussens; Min Shen; Dayle A Daines
Journal:  J Bacteriol       Date:  2019-05-22       Impact factor: 3.490

2.  Assessment of biological responses of EpiAirway 3-D cell constructs versus A549 cells for determining toxicity of ambient air pollution.

Authors:  Jose Zavala; Bridget O'Brien; Kim Lichtveld; Kenneth G Sexton; Ivan Rusyn; Ilona Jaspers; William Vizuete
Journal:  Inhal Toxicol       Date:  2016       Impact factor: 2.724

3.  Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria.

Authors:  Di Jiang; Sally E Wenzel; Qun Wu; Russell P Bowler; Christina Schnell; Hong Wei Chu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.

Authors:  Jerome Deval; Jin Hong; Guangyi Wang; Josh Taylor; Lucas K Smith; Amy Fung; Sarah K Stevens; Hong Liu; Zhinan Jin; Natalia Dyatkina; Marija Prhavc; Antitsa D Stoycheva; Vladimir Serebryany; Jyanwei Liu; David B Smith; Yuen Tam; Qingling Zhang; Martin L Moore; Rachel Fearns; Sushmita M Chanda; Lawrence M Blatt; Julian A Symons; Leo Beigelman
Journal:  PLoS Pathog       Date:  2015-06-22       Impact factor: 6.823

5.  Access to highly specialized growth substrates and production of epithelial immunomodulatory metabolites determine survival of Haemophilus influenzae in human airway epithelial cells.

Authors:  Jennifer Hosmer; Marufa Nasreen; Rabeb Dhouib; Ama-Tawiah Essilfie; Horst Joachim Schirra; Anna Henningham; Emmanuelle Fantino; Peter Sly; Alastair G McEwan; Ulrike Kappler
Journal:  PLoS Pathog       Date:  2022-01-27       Impact factor: 6.823

6.  Development of a Vitrification Preservation Process for Bioengineered Epithelial Constructs.

Authors:  Lia H Campbell; Kelvin G M Brockbank
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

7.  Characterization of extended co-culture of non-typeable Haemophilus influenzae with primary human respiratory tissues.

Authors:  Dabin Ren; Kevin L Nelson; Peter N Uchakin; Arnold L Smith; Xin-Xing Gu; Dayle A Daines
Journal:  Exp Biol Med (Maywood)       Date:  2012-05-08

Review 8.  Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.

Authors:  Charlotte De Rudder; Marta Calatayud Arroyo; Sarah Lebeer; Tom Van de Wiele
Journal:  Microbiome       Date:  2018-04-24       Impact factor: 14.650

9.  Dual and Triple Epithelial Coculture Model Systems with Donor-Derived Microbiota and THP-1 Macrophages To Mimic Host-Microbe Interactions in the Human Sinonasal Cavities.

Authors:  Charlotte De Rudder; Marta Calatayud Arroyo; Sarah Lebeer; Tom Van de Wiele
Journal:  mSphere       Date:  2020-01-15       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.